Steve E. Krognes, CFO and Treasurer at Denali Therapeutics Inc. (DNLI), sold 99,499 shares at $64.27 ($6.5M) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Open-market sale of $6.5M DNLI by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.27 | 22,684 | $1.5M | 22.5% |
| 2 | $64.27 | 22,684 | $1.5M | 22.5% |
| 3 | $65.04 | 10,199 | $663K | 10.2% |
| 4 | $65.04 | 10,199 | $663K | 10.2% |
| 5 | $66.20 | 16,616 | $1.1M | 17.0% |
| 6 | $66.20 | 16,616 |
| $1.1M |
| 17.0% |
| 7 | $66.80 | 501 | $33K | 0.5% |
| Total | $65.09 avg | 99,499 | $6.5M | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $139K | — | Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |